Fundraising Fox
Lantern Pharma
NASDAQ: LTRNDallas, US · Founded 2013 · Texas corporation · 32 employees on LinkedIn · 2 known investors
Find your way into Lantern Pharma
Sign up to see every warm intro you have to Lantern Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lantern Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lantern Pharma is a pharmaceutical biotechnology company that applies machine learning and AI to oncology drug development, using data-driven hypothesis testing with in vitro and in vivo models. Its approach stratifies patient populations into responders and non-responders to de-risk clinical trials, develop companion diagnostics, and improve the likelihood of FDA approval at reduced cost.
Founders & leadership
Lantern Pharma was founded in 2013 by Arunkumar Asaithambi.
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 2 of 4 rounds · 1900–2026
▶Undisclosed amountofferedMay 2026 · 6 investors · PharmaceuticalsRule 506(b)
- Donald Jeffrey KeyserDirector
- David R. MargraveExecutive Officer
- Panna SharmaExecutive Officer, Director
- Kishor G. BhatiaExecutive Officer
- Lee T. SchalopDirector
- Vijay ChandruDirector
- David S. SilbersteinDirector
- Maria MaccecchiniDirector
- First sale
- May 2026
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$2.4MraisedMar 2019 · 5 investors · BiotechnologyRule 506(b)
- David SilbersteinDirector
- John FucciDirector
- Arunkumar AsaithambiDirector
- Panna SharmaExecutive Officer, Director
- Donald KeyserDirector
- Offering amount
- $6.3M
- Amount sold
- $2.4M
- Proceeds to insiders
- $360K
- First sale
- Mar 2019
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$535KraisedJan 2019 · 5 investors · BiotechnologyRule 506(b)
- David SilbersteinDirector
- Panna SharmaExecutive Officer, Director
- Arunkumar AsaithambiDirector
- David KeyserDirector
- John FucciDirector
- Offering amount
- $535K
- Amount sold
- $535K
- First sale
- Dec 2018
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Lantern Pharma.
Frequently asked questions
- What does Lantern Pharma do?
- Lantern Pharma is a pharmaceutical biotechnology company that applies machine learning and AI to oncology drug development, using data-driven hypothesis testing with in vitro and in vivo models. Its approach stratifies patient populations into responders and non-responders to de-risk clinical trials, develop companion diagnostics, and improve the likelihood of FDA approval at reduced cost.
- Who founded Lantern Pharma?
- Lantern Pharma was founded by Arunkumar Asaithambi in 2013.
- Who are Lantern Pharma's investors?
- Lantern Pharma's investors include Green Park & Golf Ventures, Health Wildcatters.
- How much funding has Lantern Pharma raised?
- Lantern Pharma has disclosed $2.9M raised across 2 of its 4 known rounds.
- Where is Lantern Pharma headquartered?
- Lantern Pharma is headquartered in Dallas, US.